# Voyageur Pharmaceuticals Confirms Pharmaceutical-Grade Purity of Barite from Frances Creek and Progresses to Health Canada Human Trial with Alberta Innovates Grant; Announces Stock Option and DSU grants, and Proposed Issuance of Securities for Debt

Canonical Atlas analysis: https://atlas-extractions.minestarters.com/news/voyageur-pharmaceuticals-confirms-pharmaceutical-grade-purity-of-barite-from-fra--7309b961-0391-46cb-a28a-5256dc095bef

Original source: https://money.tmx.com/en/quote/VM/news/5469291407965030/voyageur-pharmaceuticals-confirms-pharmaceutical-grade-purity-of-barite-from-fra

Publisher: tmx

Original announcement: 2026-03-04T12:00:00.000Z

Analysis by Minestarters Atlas

Atlas analysis published: Unknown date

Atlas analysis updated: Unknown date

- Company: Voyageur Pharmaceuticals Ltd.

- Ticker: VM

- Exchange: TSX

- Region: British Columbia

- Primary commodity: Barium

- Secondary commodities: Iodine

- Document categories: Metallurgy, Other

- Extracted: 2026-09-13 06:39:32 UTC

Narrative sentiment: 0.80 · Bullish

## Minestarters Atlas summary

Voyageur Pharmaceuticals has confirmed that its Frances Creek barite achieves pharmaceutical-grade purity, with average BaSO4 levels of 98.8%, exceeding USP requirements. The company is progressing toward Health Canada human trials and has secured support through the Alberta Innovates program.

Reasoning: The announcement confirms high-purity pharmaceutical-grade barium sulfate from the Frances Creek property, a critical technical milestone for commercialization.

- Positive factor: High purity results \(98.8% average\) exceeding USP requirements

- Positive factor: Successful micronization to ultra-fine particle sizes

- Positive factor: De-risking milestone for pharmaceutical-grade API

- Positive factor: Non-dilutive funding support from Alberta Innovates

Facts used in scoring: 2

## Classification and evidence

**Free Milling**

Polarity: positive

Definition: Simple, clean ore amenable to standard processing without oxidation.

Why it applies: The material processes efficiently into ultra-fine particles with 100% yield and high purity.

Evidence · text

> demonstrated that the material processes efficiently into ultra-fine particles

**Multi-Domain Tested**

Polarity: positive

Definition: Variability across ore domains \(oxide, transition, fresh\) has been addressed.

Why it applies: 2 distinct composites were tested

## Extracted facts

Stored fact records: 2. Some facts used in scoring do not have a stored record.

## Metallurgical Results (2)

### assay

[Link to this fact](https://atlas-extractions.minestarters.com/news/voyageur-pharmaceuticals-confirms-pharmaceutical-grade-purity-of-barite-from-fra--7309b961-0391-46cb-a28a-5256dc095bef#fact-metallurgical-facts-0)

Frances Creek · barium

#### Identity

- Project: Frances Creek
- Commodity: barium
- Region: canada\_bc
- Reported Region: British Columbia
- Ticker: VM

#### Test Work

- Program Status: detailed
- Test Type: assay
- Processing Route: controlled acid-wash procedure
- Sample: Frances Creek barite API samples

#### Recovery

- Head Grade: 98.8
- Head Grade Unit: %

#### Lab

- Laboratory: SGS Laboratories

#### Review

- Needs Review: No
- Historical: No

#### Dates

- Event date: 2026-03-04T00:00:00.000Z

Reasoning: Average purity of 98.8% BaSO4 is exceptionally high for pharmaceutical applications.

- Positive factor: Purity exceeds USP monograph requirement of 97.5%

- Positive factor: Independent testing by SGS Laboratories

Evidence · text

> average grade of 98.8%

### micronization

[Link to this fact](https://atlas-extractions.minestarters.com/news/voyageur-pharmaceuticals-confirms-pharmaceutical-grade-purity-of-barite-from-fra--7309b961-0391-46cb-a28a-5256dc095bef#fact-metallurgical-facts-1)

Frances Creek · barium

#### Identity

- Project: Frances Creek
- Commodity: barium
- Region: canada\_bc
- Reported Region: British Columbia
- Ticker: VM

#### Test Work

- Test Type: micronization
- Processing Route: pharmaceutical-grade micronizing equipment
- Sample: micronized barite samples

#### Recovery

- Recovery: 100 %

#### Review

- Needs Review: No
- Historical: No

#### Dates

- Event date: 2026-03-04T00:00:00.000Z

Reasoning: Successful processing into ultra-fine particles is essential for medical imaging contrast media.

- Positive factor: 100% yield achieved

- Positive factor: Achieved ultra-fine particle sizes \(d50 1.1–1.9 µm\)

Evidence · text

> exhibited good flowability, 100% yield

## How Atlas produces this analysis

Minestarters Atlas uses automated extraction to summarize mining announcements, identify reported measurements, and classify supporting evidence. Sentiment reflects the extracted narrative and classification rules; it is an interpretation, not a reported measurement. Evidence quotes and context are provided where available. Missing data, low-confidence results, and review flags indicate limitations. Check the original publisher announcement before relying on an interpretation.